Found 12 matching trials
Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)
PHASE3The purpose of this study is to determine whether ozanimod is effective in ...
A Study to Evaluate Rebif® New Formulation (Interferon-beta-1a) in Relapsing Remitting Multiple Sclerosis
PHASE3General Note: throughout this record, "Rebif® New Formulation" is used for ...
Location
Multiple Locations
Study of Evobrutinib in Participants With Relapsing Multiple Sclerosis (RMS)
PHASE3The study was to evaluate the efficacy and safety of evobrutinib administer...
Location
Please Contact U.S. Medical Information
Safety and Efficacy of Interferon-Beta-1a (Rebif®) for Treating Subjects With Acute Symptoms of Ulcerative Colitis
PHASE2The purpose of this study is to determine the safety and efficacy of interf...
A Phase 2 Study of Cladribine Add-on to Interferon-beta (IFN-beta) Therapy in Multiple Sclerosis (MS) Subjects With Active Disease (ONWARD)
PHASE2The goal of this study was to evaluate the safety, tolerability and effecti...
A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis
PHASE3This randomized, double-blind, double-dummy, parallel-group study will eval...
Location
21st Century Neurology
Supplementation of VigantOL® Oil Versus Placebo as Add-on in Patients With Relapsing Remitting Multiple Sclerosis Receiving Rebif® Treatment
PHASE2The drug being tested is called VigantOL® oil - a very effective form of Vi...
Oral Cladribine in Early Multiple Sclerosis (MS)
PHASE3A randomized, double-blind, clinical trial to assess the safety and efficac...
Location
Hope Research Institute Medical Plaza LLC Desert Hills
Efficacy and Safety Study of Ozanimod in Relapsing Multiple Sclerosis
PHASE3This study is a two-part trial consisting of Part A (see NCT01628393) and P...
Location
Receptos Study Site 115
Long-term Follow-Up of Patients Who Participated in Study 27025 (REFLEX)
PHASE3REFLEXION is a double blind extension of the study 27025 (NCT00404352) (REF...